A Randomized, Open-Label, 2-Way Crossover, Single-Dose Food Effect Study of ZN-c5 in Healthy Adult Post-Menopausal Female Subjects
Latest Information Update: 02 Nov 2021
At a glance
- Drugs ZN c5 (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- Sponsors Zeno Alpha
- 22 Dec 2020 Status changed from active, no longer recruiting to completed.
- 09 Dec 2020 Status changed from recruiting to active, no longer recruiting.
- 02 Nov 2020 Status changed from not yet recruiting to recruiting.